Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedtime versus morning low-dose aspirin and circadian platelet function in healthy adults
NL-OMON38423Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in arterial thrombosis (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Platelet reactivity. Started Aug 2013; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
arterial thrombosis
Beyond the preview
Go deeper on NL-OMON38423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38423.